Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN-102)

Conditions: Pre-Exposure Prophylaxis of HIV Infection Interventions: Drug: Lenacapavir Tablet; Drug: Lenacapavir Injection; Drug: Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) Sponsors: Gilead Sciences; HIV Prevention Trials Network Not yet recruiting

https://clinicaltrials.gov/study/NCT06101329

Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials